Ngā hua rapu kaituhi

1

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors mā Brigitte C. Widemann

I whakaputaina 2009

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives mā Brigitte C. Widemann, Antoîne Italiano

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Understanding and Managing Methotrexate Nephrotoxicity mā Brigitte C. Widemann, Peter C. Adamson

I whakaputaina 2006

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Sorafenib and Sunitinib mā AeRang Kim, Frank M. Balis, Brigitte C. Widemann

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinics mā Lori Wiener, Haven Battles, Sima Zadeh, Brigitte C. Widemann, Maryland Pao

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Social-emotional Functioning of Children and Adolescents With Neurofibromatosis Type 1 and Plexiform Neurofibromas: Relationships With Cognitive, Disease, and Environmental Variabl... mā Staci Martin, Pamela L. Wolters, A. Baldwin, Andrea Gillespie, Eva Dombi, Katherine Walker, Brigitte C. Widemann

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies mā AeRang Kim, Douglas R. Stewart, Karlyne M. Reilly, David Viskochil, Markku Miettinen, Brigitte C. Widemann

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

$Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group$

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group mā AeRang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda J. Weigel, Susan M. Blaney

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

$Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors$

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents... mā Elizabeth Fox, Brigitte C. Widemann, Devang Pastakia, Clara C. Chen, Sherry Yang, Diane E. Cole, Frank M. Balis

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas mā A. Kim, Andrea Gillespie, Eva Dombi, Anne Goodwin, Wendy Goodspeed, Elizabeth Fox, Frank M. Balis, Brigitte C. Widemann

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas mā Regina I. Jakacki, Eva Dombi, D. Potter, Stewart Goldman, Jeffrey C. Allen, Ian F. Pollack, Brigitte C. Widemann

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors mā Jenna M. Kahn, Andy Gillespie, Maria Tsokos, John Ondos, Eva Dombi, Kevin Camphausen, Brigitte C. Widemann, Aradhana Kaushal

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1 mā Rosa Nguyen, Eva Dombi, Brigitte C. Widemann, Jeffrey Solomon, Carsten Fuensterer, Lan Kluwe, Jan M. Friedman, Victor-Felix Mautner

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques mā Anandani Nellan, Cynthia McCully, Rafael Cruz Garcia, Nalini Jayaprakash, Brigitte C. Widemann, Daniel W. Lee, Katherine E. Warren

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
15

Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1 mā Victor-F. Mautner, Florence A. Asuagbor, Eva Dombi, C. Fünsterer, Lan Kluwe, Ralf Wenzel, Brigitte C. Widemann, Jan M. Friedman

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

$Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias$

Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias mā Nirali N. Shah, Melinda S. Merchant, Diane E. Cole, Nalini Jayaprakash, Donna Bernstein, Cindy Delbrook, Kelly Richards, Brigitte C. Widemann, Alan S. Wayne

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Pediatric adrenocortical carcinoma mā Maran Ilanchezhian, Diana Grace Varghese, John Glod, Karlyne M. Reilly, Brigitte C. Widemann, Yves Pommier, Rosandra N. Kaplan, Jaydira Del Rivero

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

Achieving consensus for clinical trials mā Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy mā Staci Martin, Pamela L. Wolters, Mary Anne Toledo‐Tamula, Shawn Nelson Schmitt, Andrea Baldwin, Amy J. Starosta, Andrea Gillespie, Brigitte C. Widemann

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma mā Brigitte C. Widemann, Frank M. Balis, Beate Kempf‐Bielack, Stefan Bielack, Charles B. Pratt, Stefano Ferrari, Gaetano Bacci, Alan Craft, Peter C. Adamson

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Brigitte C. Widemann

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors mā Brigitte C. Widemann

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives mā Brigitte C. Widemann, Antoîne Italiano

Understanding and Managing Methotrexate Nephrotoxicity mā Brigitte C. Widemann, Peter C. Adamson

Sorafenib and Sunitinib mā AeRang Kim, Frank M. Balis, Brigitte C. Widemann

Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinics mā Lori Wiener, Haven Battles, Sima Zadeh, Brigitte C. Widemann, Maryland Pao

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies mā AeRang Kim, Douglas R. Stewart, Karlyne M. Reilly, David Viskochil, Markku Miettinen, Brigitte C. Widemann

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group mā AeRang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda J. Weigel, Susan M. Blaney

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents... mā Elizabeth Fox, Brigitte C. Widemann, Devang Pastakia, Clara C. Chen, Sherry Yang, Diane E. Cole, Frank M. Balis

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas mā A. Kim, Andrea Gillespie, Eva Dombi, Anne Goodwin, Wendy Goodspeed, Elizabeth Fox, Frank M. Balis, Brigitte C. Widemann

Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas mā Regina I. Jakacki, Eva Dombi, D. Potter, Stewart Goldman, Jeffrey C. Allen, Ian F. Pollack, Brigitte C. Widemann

Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors mā Jenna M. Kahn, Andy Gillespie, Maria Tsokos, John Ondos, Eva Dombi, Kevin Camphausen, Brigitte C. Widemann, Aradhana Kaushal

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1 mā Rosa Nguyen, Eva Dombi, Brigitte C. Widemann, Jeffrey Solomon, Carsten Fuensterer, Lan Kluwe, Jan M. Friedman, Victor-Felix Mautner

Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques mā Anandani Nellan, Cynthia McCully, Rafael Cruz Garcia, Nalini Jayaprakash, Brigitte C. Widemann, Daniel W. Lee, Katherine E. Warren

Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1 mā Victor-F. Mautner, Florence A. Asuagbor, Eva Dombi, C. Fünsterer, Lan Kluwe, Ralf Wenzel, Brigitte C. Widemann, Jan M. Friedman

Pediatric adrenocortical carcinoma mā Maran Ilanchezhian, Diana Grace Varghese, John Glod, Karlyne M. Reilly, Brigitte C. Widemann, ﻿Yves Pommier, Rosandra N. Kaplan, Jaydira Del Rivero

Achieving consensus for clinical trials mā Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma mā Brigitte C. Widemann, Frank M. Balis, Beate Kempf‐Bielack, Stefan Bielack, Charles B. Pratt, Stefano Ferrari, Gaetano Bacci, Alan Craft, Peter C. Adamson

Ngā utauta rapu:

Ngā marau whai pānga

Pediatric adrenocortical carcinoma mā Maran Ilanchezhian, Diana Grace Varghese, John Glod, Karlyne M. Reilly, Brigitte C. Widemann, Yves Pommier, Rosandra N. Kaplan, Jaydira Del Rivero